
Last updated: 2026-09-16 10:32:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Cellyan Biotechnology Co., Ltd (HKPD) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $0,12, with a market capitalisation of $6,16M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,11 to $1,82. This page covers its latest market performance, valuation, price trends and company information.
$6,16M | |
$0,12 | |
$3,79 | |
$0,11 | |
$0,11 | |
12,08M | |
3,42M | |
-- | |
$1,82 | |
$0,11 | |
-- | |
-- |
Cellyan Biotechnology Co., Ltd (HKPD) is trading at $0,11 in pre-market trading as of 2026-09-16 10:31:00, up 0,62% ($0,00) from the previous close of $0,11
Pre-market trading shows how investors are pricing HKPD before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Cellyan Biotechnology Co., Ltd (HKPD) moved from $0,13 to $0,12, representing a decline of 9,87% ($0,01).
The stock traded between $0,11 and $0,15 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 9,28 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0,6%
HKPD is currently trading at $0,12, placing it 0,6% of the way from its 52-week low of $0,11 to its 52-week high of $1,82. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cellyan Biotechnology Co Ltd is an integrated pharmaceutical cross-border e-commerce supply chain service provider with a professional team and related pharmaceutical storage facilities in Hong Kong. It operates through two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, referred to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, referred to as the Procurement and Distribution division. Its main business provides one-stop services for merchants engaged in cross-border pharmaceutical e-commerce, including OTC wholesale, import and export, warehousing, packaging, customs clearance and delivery to final destinations, forming a closed loop of pharmaceutical cross-border e-commerce supply chain.
| Employees | 11 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Cellyan Biotechnology Co., Ltd (HKPD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.